United States · 
Who invested in Solace Therapeutics?
Solace Therapeutics's investors include New Enterprise Associates, Saints Capital and Spray Venture Partners.
20132014
$7.0MSeries B$13MSeries BUnited States · Series B startup
Who invested in Solace Therapeutics
Funding summaryUpdated 26 Oct 2026
$20Mraised across 2 rounds since 2012, from 2 sources
$7.0MSeries B$13MSeries B
- Latest round
- Series B, $13MJun 2014
- Step-upi
- 1.9×
- Investors
- 3
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $7.0M Mar 2012
- Biggest round
- $13M Series B · Jun 2014
- Between rounds
- 2.2 years from the last two
The rounds
- Jun 2014
- Mar 2012Series B$7.0M3 new
Reported by masshightech.comSEC filing: $7.0M sold, first sale Mar 2012
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Spray Venture PartnersVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Solace Therapeutics
How much has Solace Therapeutics raised?
Solace Therapeutics has raised $20M across 2 rounds since 2012.
When did Solace Therapeutics last raise?
Solace Therapeutics's most recent round was a Series B of $13M in Jun 2014.
What was Solace Therapeutics's biggest round?
Its most recent round, $13M in Jun 2014, is also its largest on record.
Who backed Solace Therapeutics first?
Solace Therapeutics's first round on record, in Mar 2012, was backed by New Enterprise Associates, Saints Capital and Spray Venture Partners.
What stage is Solace Therapeutics at?
Solace Therapeutics's latest named round is a Series B, in Jun 2014.
Where is Solace Therapeutics based?
Solace Therapeutics is based in the United States.
Companies like Solace Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.